DYAI
Dyadic InternationalCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
DYAI vs peer average
76/100
DYAI vs. peer average (C vs. F)
Grade spread
D 3 · F 5
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
CDXS is the first available peer comparator.
Codexis remains the closest operating-model comparator in this report because its enzymatic and bioprocessing platform model is directionally relevant to Dyadic's attempt to commercialize protein-expression technology through partners. It is not a clean valuation peer because Codexis is larger, more mature, and better capitalized.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
DYAI
Dyadic International
CDXS
Codexis
Grade
C
F
Momentum
76
10
Value
41
41
Sentiment
48
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs CDXS
DYAI / CDXS
Grade Position
Above peers
DYAI vs. peer average (C vs. F)
76/100
Momentum
76
DYAIValue
41
DYAISentiment
48
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs DYAI
CDXS is the first peer returned for this comparison set.